Literature DB >> 31197741

Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Shinichiro Kumita1, Keiichiro Yoshinaga2, Masao Miyagawa3, Mitsuru Momose4, Keisuke Kiso5, Tokuo Kasai6, Masanao Naya7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31197741     DOI： 10.1007/s12350-019-01755-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  83 in total

1.  Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis.

Authors:  Chiung-Zuan Chiu; Satoshi Nakatani; Guican Zhang; Teruo Tachibana; Fumio Ohmori; Masakazu Yamagishi; Masafumi Kitakaze; Hitonobu Tomoike; Kunio Miyatake
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

2.  A mathematical model for the distribution of fluorodeoxyglucose in humans.

Authors:  M T Hays; G M Segall
Journal:  J Nucl Med       Date:  1999-08       Impact factor: 10.057

3.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Authors:  A Uemura; S Morimoto; S Hiramitsu; Y Kato; T Ito; H Hishida
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

4.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

5.  Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT?

Authors:  Frank P DiFilippo; Richard C Brunken
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

6.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.

Authors:  Hiroyuki Yamagishi; Naoya Shirai; Masahiko Takagi; Minoru Yoshiyama; Kaname Akioka; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  J Nucl Med       Date:  2003-07       Impact factor: 10.057

7.  Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.

Authors:  Nancy Paquet; Adelin Albert; Jacqueline Foidart; Roland Hustinx
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

8.  The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis.

Authors:  Tatsuro Kaminaga; Touru Takeshita; Teiyu Yamauchi; Hikaru Kawamura; Masami Yasuda
Journal:  Int J Cardiol       Date:  2004-03       Impact factor: 4.164

9.  Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction.

Authors:  Darren P Lum; Sara Wandell; Jehoon Ko; Marc N Coel
Journal:  Mol Imaging Biol       Date:  2002-05       Impact factor: 3.488

Review 10.  The glucose-fatty acid cycle: a physiological perspective.

Authors:  K N Frayn
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407
View more
  9 in total

Review 1.  Positron emission tomography/MRI for cardiac diseases assessment.

Authors:  Osamu Manabe; Noriko Oyama-Manabe; Nagara Tamaki
Journal:  Br J Radiol       Date:  2020-02-14       Impact factor: 3.039

2.  The use of systematic review evidence to support the development of guidelines for positron emission tomography: a cross-sectional survey.

Authors:  Qianrui Li; Wenxiu Hou; Ling Li; Minggang Su; Yan Ren; Wen Wang; Kang Zou; Rong Tian; Xin Sun
Journal:  Eur Radiol       Date:  2021-03-08       Impact factor: 5.315

3.  Feasibility of 18FDG PET in the cardiac inflammation.

Authors:  Sebastian Osiecki; Maciej Sterliński; Marta Marciniak-Emmons; Mirosław Dziuk
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-15       Impact factor: 2.357

Review 4.  Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis.

Authors:  Sheetal V Mathai; Snehal Patel; Ulrich P Jorde; Yogita Rochlani
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

5.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-12-01       Impact factor: 6.875

6.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-27       Impact factor: 9.236

7.  F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart.

Authors:  Eunjung Kong
Journal:  Yeungnam Univ J Med       Date:  2020-10-15

Review 8.  Advances in Diagnostic Imaging for Cardiac Sarcoidosis.

Authors:  Osamu Manabe; Noriko Oyama-Manabe; Tadao Aikawa; Satonori Tsuneta; Nagara Tamaki
Journal:  J Clin Med       Date:  2021-12-11       Impact factor: 4.241

9.  Left Ventricular Dysfunction Caused by IgG4-related Small Intramural Coronary Periarteritis.

Authors:  Tasuku Hada; Masashi Amano; Yuki Irie; Kenji Moriuchi; Atsushi Okada; Manabu Matsumoto; Hiroyuki Takahama; Makoto Amaki; Hideaki Kanzaki; Yoshihiko Ikeda; Kinta Hatakeyama; Kengo Kusano; Teruo Noguchi; Chisato Izumi
Journal:  Intern Med       Date:  2021-07-03       Impact factor: 1.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.